{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-027680","form_type":"8-K","ticker":"NXPL","cik":"0001058307","company_name":"NextPlat Corp","filed_at":"2026-08-13T20:16:08+00:00","discovered_at":"2026-08-13T20:18:00.224853+00:00","generated_at":"2026-08-13T20:18:28.223030+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"NextPlat Q2 revenue up 21% sequentially to $11.9M; net loss down 87% to $144K","bullets":["Q2 revenue $11.9M, +21% sequentially; gross margin record 40% vs 35% prior quarter.","Net loss attributable to common stockholders $0.1M ($0.05/diluted share) vs $1.8M ($0.69) year ago.","Contracted pharmacy revenue up 136% YoY to $2.2M; e-commerce revenue $4.1M, +27% sequentially.","Cash $11.9M, working capital $14.2M, no material unsecured debt; 11 new contracted entities signed in H1.","Intends to acquire profitable pharmacy operation in Pensacola, FL; new nationwide medication fulfillment website expected Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-027680","json":"https://secwatch.observer/filing/0001437749-26-027680.json","markdown":"https://secwatch.observer/filing/0001437749-26-027680.md","text":"https://secwatch.observer/filing/0001437749-26-027680.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1058307/000143774926027680/0001437749-26-027680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1058307/000143774926027680/nxpl20260526_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T20:18:28.223030+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}